Claudine Kieda, Research Director Emeritus at the CBM, honored at the “Outstanding Poles in France” gala.

 

This action by the Polish Polskie Godlo Promocyjne Teraz Polska Foundation is awarded to Polish and Polish people permanently residing in France who have achieved great success in their work, who are recognized in their communities for initiatives and activities to promote a positive image of Poland and the Poles.

The aim is to make these people better known in France and also in Poland, where they often remain anonymous.

The title "Outstanding Polish" can be awarded in the following five categories: Business, Culture, Research / Science, Personality and "Young Poles".

 

symposium “Alzheimer’s disease”

This conference is organized and coordinated by the students who will speak on 4 major axes (sessions):

Session 1: Molecular basis of Alzheimer's pathology,

Session 2: Orthoptic and transgenic animal models,

Session 3: Markers and non-invasive diagnosis,

Session 4: Current and Future Therapeutic Approaches.

The symposium is organized with the presence of a Chairman and moderators for each session.

A CBM project winner of the CNRS premature program

This project entitled "Preclinical Validation of LIMK Inhibitors in Cancer" will receive specific financial support. It is led by Hélène Benedetti, a researcher at the Center for Molecular Biophysics (CBM), and Sylvain Routier, a researcher at the Institute of Organic and Analytical Chemistry (ICOA). Its goal is to determine the efficacy of inhibitors, protein kinases LIMKs, new therapeutic targets particularly interesting to treat cancers for which existing therapies are ineffective. Prematuration will make it possible to characterize the cellular effect of these compounds and to determine their pharmacokinetic properties with a view to performing in vivo tests on three cancer models.

New models to predict and study the effects of cosmetic compounds

Evaluating the activity of compounds on the skin and understanding their mechanisms of action have become unavoidable steps to select and develop a dermocosmetic product. Since the ban on the use of animals in the cosmetic field, many "models" have been  developed, especially with recent advances in research in skin biology and computer science.

The book "Modèles pour l'évaluation des produits cosmétiques, de la molécule à l'humain", coordinated by Catherine Grillon, Leader of the Skin Biology Group at CBM, and Marek Haftek of the Laboratory of Tissue Biology and Therapeutic Engineering de Lyon, gives an overview of all the models used to evaluate the activity of dermocosmetic compounds, with their advantages, disadvantages and limitations. This book, edited by Cosmetic Valley Editions, brings together academic and industrial researchers, all specialists in their field, ranging from in silico prediction to in vivo evaluations, to all in vitro cell models, from the simplest to the most complex.